Advanced targeted therapies dominate treatment pipeline for colorectal cancer, finds
A vast number and variety of remedies are steadily joining the treatment pipeline for colorectal cancer. High incidence of the disease, unmet clinical needs, and huge commercial potential are attracting drug developers to the market.